Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial
Lambertini M.
•
Poggio F.
•
Bruzzone M.
altro
Del Mastro L.
2019